Published in Int Ophthalmol on February 19, 2012
Myopic choroidal neovascularisation: current concepts and update on clinical management. Br J Ophthalmol (2014) 1.02
Prevalence and risk factors for refractive errors in adult Chinese in Singapore. Invest Ophthalmol Vis Sci (2000) 3.76
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1. Ophthalmology (2001) 3.12
Prevalence of myopia in the United States. Arch Ophthalmol (1983) 3.00
Refractive status in the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci (1994) 2.36
Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology (1984) 2.03
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3. Ophthalmology (2003) 1.96
Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularization. Ophthalmology (1999) 1.72
Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia. Br J Ophthalmol (2003) 1.66
Pathologic myopia: where are we now?. Am J Ophthalmol (2002) 1.62
Visual prognosis of disciform degeneration in myopia. Ophthalmology (1983) 1.34
Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study. Ophthalmology (2007) 1.26
Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results. Am J Ophthalmol (2008) 1.18
Surgical removal of subfoveal choroidal neovascularisation in highly myopic patients. Br J Ophthalmol (2001) 1.09
Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment. Am J Ophthalmol (2004) 1.08
Characteristics of patients with a favorable natural course of myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol (2004) 1.04
On the definition of pathologic myopia in group studies. Acta Ophthalmol Suppl (1988) 1.03
Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up. Br J Ophthalmol (2004) 0.93
Choroidal neovascularization in pathologic myopia: three-year results after photodynamic therapy. Am J Ophthalmol (2005) 0.93
Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia. Retina (2007) 0.92
Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia. Am J Ophthalmol (2004) 0.88
Choroidal neovascularization in degenerative myopia: role of laser photocoagulation. Ophthalmic Surg (1987) 0.88
Subretinal surgery for choroidal neovascularization in patients with high myopia. Arch Ophthalmol (2000) 0.87
Intravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal neovascularization. Eur J Ophthalmol (2007) 0.84
Estimation of visual outcome without treatment in patients with subfoveal choroidal neovascularization in pathologic myopia. Graefes Arch Clin Exp Ophthalmol (2006) 0.84
Heritability of myopic refractive errors in identical and fraternal twins. Graefes Arch Clin Exp Ophthalmol (1993) 0.84
[Subretinal neovessels in degenerative myopia: results of photocoagulation]. Bull Soc Ophtalmol Fr (1986) 0.80
Optical coherence tomography to monitor photodynamic therapy in pathological myopia. Br J Ophthalmol (2006) 0.75
Endophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: incidence and outcomes. Retina (2008) 1.57
Quantitative analysis of subfoveal choroidal thickness using enhanced depth imaging optical coherence tomography in normal eyes. Int Ophthalmol (2013) 1.41
Incidence of endophthalmitis after 20-gauge vs 23-gauge vs 25-gauge pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol (2010) 1.33
Evaluation of macular changes after uncomplicated phacoemulsification surgery by optical coherence tomography. Curr Eye Res (2007) 1.20
Active removal of silicone oil with 25-gauge sutureless system. Retina (2007) 1.14
Ocular trauma score in open-globe injuries. J Trauma (2009) 1.09
Removal of silicone oil with 25-gauge transconjunctival sutureless vitrectomy system. Retina (2007) 1.01
Secondary iris claw intraocular lens implantation for the correction of aphakia after pars plana vitrectomy. Retina (2010) 1.01
Acute-onset endophthalmitis after cataract surgery: success of initial therapy, visual outcomes, and related factors. Retina (2009) 0.99
Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD. Retina (2009) 0.95
Early postoperative hypotony after 25-gauge sutureless vitrectomy with straight incisions. Retina (2008) 0.94
Isolates and antibiotic sensitivity of eighty culture-proven endophthalmitis cases from Istanbul. Ophthalmologica (2008) 0.93
Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation. Retina (2008) 0.92
Acute endophthalmitis after 25-gauge sutureless vitrectomy. Int Ophthalmol (2007) 0.91
Transconjunctival 25-gauge sutureless vitrectomy and silicone oil injection in diabetic tractional retinal detachment. Retina (2008) 0.90
Passive removal of silicone oil with a 25-gauge sutureless system. Jpn J Ophthalmol (2008) 0.89
25-gauge sutureless vitrectomy in osteogenesis imperfecta type I. Retin Cases Brief Rep (2009) 0.89
25-Gauge sutureless vitrectomy with oblique sclerotomies for the management of retinal detachment in pseudophakic and phakic eyes. Eur J Ophthalmol (2009) 0.86
Delayed-onset streptococcus pyogenes endophthalmitis following Ahmed glaucoma valve implantation. Jpn J Ophthalmol (2005) 0.85
Primary 25-gauge sutureless vitrectomy with oblique sclerotomies in pseudophakic retinal detachment. Retina (2008) 0.84
Hemorrhagic age-related macular degeneration managed with vitrectomy, subretinal injection of tissue plasminogen activator, gas tamponade, and upright positioning. Ophthalmic Surg Lasers Imaging Retina (2013) 0.83
The use of blood culture bottles in endophthalmitis. Retina (2007) 0.82
Prognostic factors in severely traumatized eyes with posterior segment involvement. Ulus Travma Acil Cerrahi Derg (2009) 0.81
Comparative outcomes of pars plana vitrectomy in acute postoperative endophthalmitis with 25-gauge and 20-gauge techniques. Jpn J Ophthalmol (2009) 0.79
Pars plana vitrectomy with and without triamcinolone acetonide assistance in pseudophakic retinal detachment complicated with proliferative vitreoretinopathy. Jpn J Ophthalmol (2010) 0.77
Pars plana vitrectomy revealed Toxocara canis organism. Int Ophthalmol (2007) 0.76
Wide-Field Landers Keratoprothesis in Various Combined Corneal and Vitreoretinal Problems: Twelve-Month Results. Ophthalmic Surg Lasers Imaging Retina (2017) 0.75
Triamcinolone applicator cannula. Retina (2008) 0.75
Removal of large subretinal foreign bodies with bimanual vitrectomy and use of a suture loop. Retin Cases Brief Rep (2009) 0.75
Mitomycin protection of peridural fibrosis in lumbar disc surgery. J Neurosurg Spine (2008) 0.75
Results of Peripheral Vitrectomy Under Air in Rhegmatogenous Retinal Detachment. Ophthalmic Surg Lasers Imaging Retina (2017) 0.75